SGTX Insider Trading Activity and SEC Form 4 Filings
SGTX insider trading summary
No open-market insider purchases or sales of Sigilon Therapeutics, Inc. (SGTX) have been reported on SEC Form 4 in the past 12 months.
Latest SGTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 11, 2023 | ELI LILLY & Co | 10% Owner | Buy | $25.6M (1,718,493 @ $14.92) |
| Aug 11, 2023 | Shenandoah Acquisition Corp | 10% Owner | Buy | $25.6M (1,718,493 @ $14.92) |
| Jul 1, 2021 | Robert R Ruffolo | Insider | Sell | $70K (6,750 @ $10.36) |
| Jun 2, 2021 | Daniel Griffith Anderson | Insider | Sell | $2.0M (200,000 @ $10.00) |
| Dec 8, 2020 | ELI LILLY & Co | 10% Owner | Buy | $5.4M (300,000 @ $18.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.